2019 annual financial data
Spyre Therapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -80,334,000 USD and net income was -78,254,000 USD.
Operating cash flow was -65,692,000 USD.
Get free Spyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -80,334,000 USD
- Net income
- -78,254,000 USD
- Operating cash flow
- -65,692,000 USD